 |
PDBsum entry 6r2c
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
6r2c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Conformational transitions in the active site of mycobacterial 2-Oxoglutarate dehydrogenase upon binding phosphonate analogues of 2-Oxoglutarate: from a michaelis-Like complex to thdp adducts.
|
 |
|
Authors
|
 |
T.Wagner,
A.Boyko,
P.M.Alzari,
V.I.Bunik,
M.Bellinzoni.
|
 |
|
Ref.
|
 |
J Struct Biol, 2019,
208,
182-190.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Mycobacterial KGD, the thiamine diphosphate (ThDP)-dependent E1o component of
the 2-oxoglutarate dehydrogenase complex (OGDHC), is known to undergo
significant conformational changes during catalysis with two distinct
conformational states, previously named as the early and late state. In this
work, we employ two phosphonate analogues of 2-oxoglutarate (OG), i.e. succinyl
phosphonate (SP) and phosphono ethyl succinyl phosphonate (PESP), as tools to
isolate the first catalytic steps and understand the significance of
conformational transitions for the enzyme regulation. The kinetics showed a more
efficient inhibition of mycobacterial E1o by SP (Ki
0.043 ± 0.013 mM) than PESP (Ki 0.88 ± 0.28 mM),
consistent with the different circular dichroism spectra of the corresponding
complexes. PESP allowed us to get crystallographic snapshots of the
Michaelis-like complex, the first one for 2-oxo acid dehydrogenases, followed by
the covalent adduction of the inhibitor to ThDP, mimicking the
pre-decarboxylation complex. In addition, covalent ThDP-phosphonate complexes
obtained with both compounds by co-crystallization were in the late
conformational state, probably corresponding to slowly dissociating
enzyme-inhibitor complexes. We discuss the relevance of these findings in terms
of regulatory features of the mycobacterial E1o enzymes, and in the perspective
of developing tools for species-specific metabolic regulation.
|
 |
|
|
|
|
 |